{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:51:34Z","timestamp":1794649894752,"version":"4.9.1"},"reference-count":9,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>A recent study demonstrated that NKX3.1-positive staining can uncommonly be seen in testicular Sertoli cell tumors (1 of 4 cases). Also, it was reported that 2 of 3 Leydig cell tumors of the testis showed diffuse cytoplasmic staining for P501S, although it was unclear whether it was specific granular staining that defines true positivity. However, Sertoli cell tumors do not typically pose a diagnostic dilemma with metastatic prostate carcinoma to the testis. In contrast, malignant Leydig cell tumors, which are exceedingly rare, can closely resemble Gleason score 5 + 5 = 10 prostatic adenocarcinoma metastatic to the testis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To evaluate the expression of prostate markers in malignant Leydig cell tumors and steroidogenic factor 1 (SF-1) in high-grade prostate adenocarcinoma, as no data are currently published on these topics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Fifteen cases of malignant Leydig cell tumor were collected from 2 large genitourinary pathology consult services in the United States from 1991 to 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>All 15 cases were negative immunohistochemically for NKX3.1, and all 9 with available additional material were negative for prostate-specific antigen and P501S and positive for SF-1. SF-1 was negative immunohistochemically in a tissue microarray with cases of high-grade prostatic adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>The diagnosis of malignant Leydig cell tumor and its distinction from metastatic adenocarcinoma to the testis can be made immunohistochemically on the basis of SF-1 positivity and negativity for NKX3.1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0424-oa","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T15:41:54Z","timestamp":1678203714000},"page":"1458-1460","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis"],"prefix":"10.5858","volume":"147","author":[{"given":"Eric","family":"Erak","sequence":"first","affiliation":[{"name":"From the Department of Pathology (Erak, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ulbright","sequence":"additional","affiliation":[{"name":"The Department of Pathology, Indiana University School of Medicine, Indianapolis (Ulbright)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Epstein","sequence":"additional","affiliation":[{"name":"From the Department of Pathology (Erak, Epstein), The Johns Hopkins Hospital, Baltimore, Maryland"},{"name":"The Department of Urology (Epstein), The Johns Hopkins Hospital, Baltimore, Maryland"},{"name":"The Department of Oncology (Epstein), Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"issue":"(10)","key":"2023112714490834100_i1543-2165-147-12-1458-b01","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/PAS.0000000000001704","article-title":"Immunohistochemical characterization of 120 testicular sex cord-stromal tumors with an emphasis on the diagnostic utility of SOX9, FOXL2, and SF-1","volume":"45","author":"Lau","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"(8)","key":"2023112714490834100_i1543-2165-147-12-1458-b02","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/humrep\/dez083","article-title":"Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study","volume":"34","author":"Pozza","year":"2019","journal-title":"Hum Reprod"},{"issue":"(3)","key":"2023112714490834100_i1543-2165-147-12-1458-b03","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000478-198503000-00002","article-title":"Leydig cell tumors of the testis: a clinicopathologic analysis of 40 cases and review of the literature","volume":"9","author":"Kim","year":"1985","journal-title":"Am J Surg Pathol"},{"issue":"(1)","key":"2023112714490834100_i1543-2165-147-12-1458-b04","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAS.0000000000001367","article-title":"NKX3.1 and prostein expression in testicular tissue and sex cord-stromal tumors","volume":"44","author":"Arnesen","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"(6)","key":"2023112714490834100_i1543-2165-147-12-1458-b05","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/iju.13593","article-title":"Epidemiology of prostate cancer in Asian countries","volume":"25","author":"Kimura","year":"2018","journal-title":"Int J Urol"},{"issue":"(2)","key":"2023112714490834100_i1543-2165-147-12-1458-b06","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/00365598309180177","article-title":"Metastases to the spermatic cord, epididmymis, and testicles from carcinoma of the prostate\u2014five cases","volume":"17","author":"Johansson","year":"1983","journal-title":"Scand J Urol Nephrol"},{"issue":"(1)","key":"2023112714490834100_i1543-2165-147-12-1458-b07","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pathol.2017.07.013","article-title":"Pitfalls in the interpretation of specimens from patients with testicular tumours, with an emphasis on variant morphologies","volume":"50","author":"Ulbright","year":"2018","journal-title":"Pathology"},{"issue":"(8)","key":"2023112714490834100_i1543-2165-147-12-1458-b08","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","article-title":"NKX3.1 as a marker of prostatic origin in metastatic tumors","volume":"34","author":"Gurel","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"(9)","key":"2023112714490834100_i1543-2165-147-12-1458-b09","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/PAS.0b013e3180536678","article-title":"The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate","volume":"31","author":"Sheridan","year":"2007","journal-title":"Am J Surg Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/12\/1458\/3293811\/i1543-2165-147-12-1458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/12\/1458\/3293811\/i1543-2165-147-12-1458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:10Z","timestamp":1764790870000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/147\/12\/article-p1458.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":9,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,3,7]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0424-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,7]]}}}